Many studies on the hypocholesterolemic effects of soy proteins 1, 2) have supported the hypothesis that a peptide with high bile acid-binding ability could inhibit the reabsorption of bile acid in the ileum, or decrease the micellar solubility of cholesterol in the small intestinal epithelial cells and decrease the blood cholesterol level.
Soybean glycinin (11S globulin) has five subunits which are classified into two groups according to their homology in amino acid sequences (group I, A1aB1b, A1bB2 and A2B1a; group II, A3B4 and A5A4B3). We have reported from the previous study 3) that acidic polypeptide A1a of A1aB1b had higher bile acidbinding ability than that of A3 of A3B4 and also identified the potential bile acid-binding peptide, VAWWMY, in the A1a polypeptide.
Bioactive peptides derived from food proteins sometimes have beneficial effects on human health. It is therefore reasonable to assume that food protein quality can be improved by introducing a favorable oligopeptide sequence through site-directed mutagenesis of the genes. Makino and co-workers 4, 5) have reported that acidic polypeptides A1a and A2 had bile acid-binding abilities, and we have confirmed this. 3) In the present study, we introduced the VAWWMY sequence into glycinin A1a polypeptide to improve its bile acid-binding ability and also investigated attainment of the correct conformation for proglycinin A1aB1b with the VAWWMY sequence.
To introduce the VAWWMY sequence by replacement, we selected the regions from 251 to 256 and 282 to 287 amino acids in variable region IV, which is longest among the five variable regions, 6) because this region has been proven to have high tolerance to modification. 7) To construct the expression plasmids (pEA1aM1, pEA1aM2, pEA1aB1bM1 and pEA1aB1bM2) for A1aM1, A1aM2, A1aB1bM1 and A1aB1BM2 (Fig. 1 0 -CCACGCAACGGGGCGTTGGCAGTGTTTG-TCTTTACCCTTG-3 0 for A1aB1bM2) were designed. The DNAs for modified versions of A1a and A1aB1b were amplified by the polymerase chain reaction (PCR), using pEA1a
3) and pEA1aB1b 8) as templates. After phosphorylation with T4 polynucleotide kinase (Toyobo), the PCR products were self-ligated with a DNA ligation kit (Takara). The sequences of the DNA regions corresponding to the coding regions were confirmed by using a 310 automated DNA sequencer (Applied Biosystems).
Five hundred ml of a TB medium containing 50 g/ ml of carbenicillin was inoculated with 4 ml of a fully grown culture of BL21(DE3) (Novagen) harboring pEA1a, pEA1aM1 and pEA1aM2, and of AD494(DE3) (Novagen) harboring pEA1aB1b, pEA1aB1bM1 and pEA1aB1bM2, and the culture was incubated with shaking at 37 C. When the OD 600 value of the culture * Present address: Laboratory of Applied Molecular Design, Marine Biotechnology Institute, Kamaishi, Iwate 026-0001, Japan y To whom correspondence should be addressed. Fax: +81-774-38-3761; E-mail: sutsumi@kais.kyoto-u.ac.jp
Biosci. Biotechnol. Biochem., 68 (9), [1980] [1981] [1982] [1983] 2004 Note had reached about 0.5, isopropyl--D-thiogalactopyranoside was added to a final concentration of 1 mM and cultivation continued for a further 16 hr at 37 C for normal A1a and its modified versions, and at 25 C for normal A1aB1b and its modified versions. The cells were then harvested by centrifugation and stored at À80 C until their further use. Frozen cells containing normal A1a and its modified versions were resuspended in 10 ml of a buffer (50 mM Tris-HCl, pH 8.0, 0.2 M NaCl, 10 mM EDTA, 0.1 mM (pamidinophenyl)-methylsulfonyl fluoride, 1 M pepstatin A and 2 M leupeptin) per gram of cells and disrupted by sonication on ice and centrifuged at 10,000 g for 10 min at 4 C ( Fig. 2A) . We used the insoluble fraction of each for purification to ensure simplicity. The precipitate was washed twice with the foregoing buffer to remove the soluble proteins. The pellet was dissolved in 4 M urea and clarified by centrifugation at 14,000 g for 40 min at 4 C. The concentration of protein in the sample was determined with a protein assay kit (BioRad) according to the manufacturer's instructions. The purity of A1a, A1aM1 and A1aM2 (Fig. 2B) was respectively calculated to be 90%, 88% and 92% densitometrically by using NIH image program.
To compare the bile acid-binding ability of expressed normal A1a and its modified versions, the fluorescence of proteins was measured with an F-3000 fluorescence spectrophotometer (Hitachi), and the dissociation constant (Kd) of each sample for sodium cholate was calculated by the Kaleida graph as previously described.
3) This measurement was done in 4 M urea, since the Kd values of normal A1a in 0, 1, 2, 3 and 4 M urea were very similar to each other. The Kd values of A1aM1 and A1aM2 were 30 and 37 mM, respectively, which are lower than 49 mM of A1a. In other words, both modified A1a versions exhibited higher bile acid-binding ability compared to the normal A1a chain.
In order to learn whether proglycinin A1aB1b could tolerate the modifications without misfolding of the protein structure, we constructed expression plasmids for modified versions A1aB1bM1 and A1aB1bM2 in which the VAWWMY peptide sequence had been respectively introduced at the same site as that of A1aM1 and A1aM2. We have previously proposed that the criteria for judging proper conformation should be as follows: (1) the solubility should be comparable with that of globulins, (2) there must be self-assembly into trimers, and (3) there must be high-level expression (=10% of total E. coli proteins). 7, 9) Densitometric scanning of the gels showed that the expression levels of normal A1aB1b, A1aB1bM1 and A1aB1bM2 were more than 20% of total E. coli proteins, and 85%, 70% and 60% of expressed normal A1aB1b, A1aB1bM1 and A1aB1bM2 were respectively recovered in the soluble fraction ( Fig. 3-1) . To examine self-assembly of the modified A1aB1b versions into trimers, the soluble fractions of A1aB1bM1 and A1ab1bM2 proteins were applied to a HiPrep 16/60 Sephacryl S-300 HR column (Pharmacia Biotech). Mature glycinin purified from soybean seeds 10) and BSA (Wako) were applied to the same column as size markers. The flow rate was 0.5 ml/ min, 2-ml fractions were collected, and the fractions were analysed by SDS-PAGE (Fig. 3-2A ) and western blotting (Fig. 3-2B,C) . The modified A1aB1b versions resolved by SDS-PAGE were transferred to nitrocellulose membranes and incubated with the anti-A1aB1b serum.
11) Glycinin, normal A1aB1b and BSA were mainly eluted at 103 min, 123 min and 136 min, respectively ( Fig. 3-2) . The elution time (123 min) of the main peak of both A1aB1bM1 and A1ab1bM2 was identical to that of normal A1aB1b (Fig. 3-2) . These results indicate that both A1aB1bM1 and A1ab1bM2 could self-assembled into trimers such as normal A1aB1b. Since these results satisfy the three criteria just described, we conclude that the modified A1aB1b versions were able to assume the correct conformation, although their folding ability was a little lower than normal A1aB1b. Correct folding of modified glycinin precursors in E. coli has resulted in the accumulation of modified mature glycinins in the protein storage vacuole of tobacco 11) and rice. 8) This suggests that it will be possible to create transgenic crops that accumulate modified glycinin with improved bile acid-binding ability.
Some successful attempts have recently been made to improve the physiological functions of food proteins by introducing a favorable oligopeptide sequence by sitedirected mutagenesis of the genes. 12, 13) However, this study is the first report on the improvement of bile acidbinding ability of glycinin by the incorporation of the VAWWMY sequence.
